loader image

QUANTUM - DRIVEN THERANOSTICS PLATFORM

EVENTS & COMMUNITY

EVENTS & COMMUNITY

At the heart of the ICPO Foundation’s mission lies the development of a strong global network of experts dedicated to advancing theranostics. This ICPO Community unites leaders from clinical practice, research, industry, and non-profit associations as well as nuclear medicine societies. To connect with experts across continents and stay at the forefront of Theranostics innovation the ICPO Foundation hosts two flagship events and participates in conferences on nuclear medicine and Theranostics worldwide.

QUANTALPHA | QUANTALPHA | QUANTALPHA | 

Upcoming

NOV 12 &13, 2026

QUANTALPHA THERANOSTICS VIRTUAL SUMMIT 2026

Where you meet us next

QUANTALPHA FORUM FOR THERANOSTICS IN PRECISION ONCOLOGY

At the heart of the ICPO Foundation’s mission lies the development of a strong global network of experts dedicated to advancing theranostics. This ICPO Community unites leaders from clinical practice, research, industry, and non-profit associations as well as nuclear medicine societies. To connect with experts across continents and stay at the forefront of Theranostics innovation the ICPO Foundation hosts two flagship events and participates in conferences on nuclear medicine and Theranostics worldwide.

IN GRATITUDE TO 2025 QUANTALPHA FORUM SPONSORS

Latest Events

4th ICPO Forum 2025 on 16 & 16, 2025 near Munich on TUM campus: Advancing Theranostics in Precision Oncology

Over 220 experts from 27 countries came together to shape the future...
Read More

QUANTALPHA VIRTUAL THERANOSTICS SUMMIT 2024

The chairs, Prof. Richard P. Baum and Prof. Frederik L. Giesel, guided...
Read More

Facts & Figures

TESTIMONIALS

“I attended every lecture from Boston, USA, and enjoyed every one of them (even today at 3 am in the morning…) including the panels. It was wonderful to see that biological knowledge needs indeed to be fully understood and included in our decision making in order to make the best decision both for the diagnosis and the treatment of cancer on a patient-centric base for clinical trials and in routine care.“

Prof. Annick D. Van den Abbeele,

Professor of Radiology, Harvard Medical School, Boston, USA
“The ICPO Forum for Theranostics 2025 has demonstrated the fast evolution of our field and current challenges this brings. ICPO has a role to play especially towards low and medium countries which represent huge patient numbers and unmet clinical needs. The interdisciplinary energy created during the ICPO Forum is exactly what we need to advance Theranostics. The discussions clearly illustrated that Theranostics is becoming a new and valuable pillar of precision oncology.”

Prof. Ken Herrmann

Chair of the Department of Nuclear Medicine, University Hospital Essen Germany